Remacemide
From Wikipedia, the free encyclopedia
This is an old revision of this page, as edited by Beetstra (talk | contribs) at 15:32, 26 January 2009 (Reverted edits by 70.137.173.82 (talk) to last version by Harbinary). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 15:32, 26 January 2009 by Beetstra (talk | contribs) (Reverted edits by 70.137.173.82 (talk) to last version by Harbinary)
 | |
| Clinical data | |
|---|---|
| Other names | 2-amino-N-[1,2-di(phenyl)propan-2-yl]acetamide |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C17H20N2O |
| Molar mass | 268.3535 g/mol g·mol−1 |
Remacemide is a low-affinity NMDA antagonist with sodium channel blocking properties.[1][2]
 | This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
References
- ^ Wright LK, Pearson EC, Hammond TG, Paule MG.Behavioral effects associated with chronic ketamine or remacemide exposure in rats. Neurotoxicol Teratol. 2007 May-Jun;29(3):348-59.
- ^ A. G. Dyker, MD, MRCP K. R. Lees, MD, FRCP. Remacemide Hydrochloride : A Double-Blind, Placebo-Controlled, Safety and Tolerability Study in Patients With Acute Ischemic Stroke Stroke. 1999;30:1796-1801.
| |||||||||||||||||||||||||||||||||||||
Hidden categories:
- Chem-molar-mass both hardcoded and calculated
- Infobox-drug molecular-weight unexpected-character
- Pages using infobox drug with unknown parameters
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs missing an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- All stub articles